These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16878478)

  • 21. Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice.
    Montaño-Hirose JA; Lafage M; Weber P; Badrane H; Tordo N; Lafon M
    Vaccine; 1993 Sep; 11(12):1259-66. PubMed ID: 8256507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus.
    Shipley R; Wright E; Smith SP; Selden D; Fooks AR; Banyard AC
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Australian bat lyssavirus infection in three fruit bats from north Queensland.
    Speare R; Skerratt L; Foster R; Berger L; Hooper P; Lunt R; Blair D; Hansman D; Goulet M; Cooper S
    Commun Dis Intell; 1997 May; 21(9):117-20. PubMed ID: 9145563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rabies Antibody Response After Booster Immunization: A Systematic Review and Meta-analysis.
    Langedijk AC; De Pijper CA; Spijker R; Holman R; Grobusch MP; Stijnis C
    Clin Infect Dis; 2018 Nov; 67(12):1932-1947. PubMed ID: 29788204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental infection of foxes with European bat lyssaviruses type-1 and -2.
    Picard-Meyer E; Brookes SM; Barrat J; Litaize E; Patron C; Biarnais M; Healy DM; Johnson L; Fooks AR; Cliquet F
    Dev Biol (Basel); 2008; 131():339-45. PubMed ID: 18634496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fatal human rabies caused by European bat Lyssavirus type 2a infection in Scotland.
    Nathwani D; McIntyre PG; White K; Shearer AJ; Reynolds N; Walker D; Orange GV; Fooks AR
    Clin Infect Dis; 2003 Aug; 37(4):598-601. PubMed ID: 12905146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabies and African bat lyssavirus encephalitis and its prevention.
    Warrell M
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S47-52. PubMed ID: 20801003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surveillance for European bat lyssavirus in Swiss bats.
    Megali A; Yannic G; Zahno ML; Brügger D; Bertoni G; Christe P; Zanoni R
    Arch Virol; 2010 Oct; 155(10):1655-62. PubMed ID: 20803042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lyssavirus infection: 'low dose, multiple exposure' in the mouse model.
    Banyard AC; Healy DM; Brookes SM; Voller K; Hicks DJ; Núñez A; Fooks AR
    Virus Res; 2014 Mar; 181():35-42. PubMed ID: 24380842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Discussion on the article Ondrejková A et al.: Transmission of lyssavirus infections from bats to man. Klin mikrobiol inf lek 2003;9:280-3].
    Benes J; Korínková M
    Klin Mikrobiol Infekc Lek; 2004 Feb; 10(1):34. PubMed ID: 15100983
    [No Abstract]   [Full Text] [Related]  

  • 31. First isolation of EBLV-2 in Germany.
    Freuling C; Grossmann E; Conraths FJ; Schameitat A; Kliemt J; Auer E; Greiser-Wilke I; Müller T
    Vet Microbiol; 2008 Sep; 131(1-2):26-34. PubMed ID: 18424021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
    Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
    Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross reactive antigenicity in orally vaccinated foxes and raccoon dogs against European Bat Lyssavirus type 1 and 2.
    Müller T; Selhorst T; Burow J; Schameitat A; Vos A
    Dev Biol (Basel); 2006; 125():195-204. PubMed ID: 16878477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Australian bat lyssavirus infection in a captive juvenile black flying fox.
    Field H; McCall B; Barrett J
    Emerg Infect Dis; 1999; 5(3):438-40. PubMed ID: 10341182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European bat lyssaviruses: Distribution, prevalence and implications for conservation.
    Harris SL; Brookes SM; Jones G; Hutson AM; Racey PA; Aegerter J; Smith GC; McElhinney LM; Fooks AR
    Biol Conserv; 2006 Aug; 131(2):193-210. PubMed ID: 32226078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology of bat lyssaviruses in Europe.
    McElhinney LM; Marston DA; Leech S; Freuling CM; van der Poel WH; Echevarria J; Vázquez-Moron S; Horton DL; Müller T; Fooks AR
    Zoonoses Public Health; 2013 Feb; 60(1):35-45. PubMed ID: 22937876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Public health concerns in bat rabies across Europe.
    Stantic-Pavlinic M
    Euro Surveill; 2005 Nov; 10(11):217-20. PubMed ID: 16371689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bat rabies--a Gordian knot?
    Freuling C; Vos A; Johnson N; Fooks AR; Müller T
    Berl Munch Tierarztl Wochenschr; 2009; 122(11-12):425-33. PubMed ID: 19999377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
    Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
    Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and serological survey of lyssaviruses in Croatian bat populations.
    Šimić I; Lojkić I; Krešić N; Cliquet F; Picard-Meyer E; Wasniewski M; Ćukušić A; Zrnčić V; Bedeković T
    BMC Vet Res; 2018 Sep; 14(1):274. PubMed ID: 30189884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.